‘‘On water’’ synthesis of spiro-indoles via Schiff bases
1193
134.6, 139.5, 152.8, 158.4, 172.6 (C-2), 176.5 (thiazolidine
C=O) ppm; MS: m/z = (ES?) 368.19 [M? ? 1], (ES-)
366.19 [M? - 1].
70.4 (spiro carbon), 112.1, 114.3, 115.9, 117.9, 118.4,
127.3, 130.6, 138.8, 152.3, 154.4, 171.8 (C-2), 176.2
(thiazolidine C=O) ppm; MS: m/z = (ES?) 311.19
[M? ? 1], (ES-) 309.21 [M? - 1].
30-(1H-Indazol-5-yl)-5-methylspiro[3H-indole-3,20-
thiazolidine]-2,40(1H)-dione (5f, C18H14N4O2S)
5-Fluoro-30-(4-methylphenyl)spiro[3H-indole-3,20-
thiazolidine]-2,40(1H)-dione (5q, C17H13FN2O2S)
ꢀ
IR (KBr): m = 3,424, 2,926, 1,720, 1,685, 1,494, 1,380,
1
1,209, 942, 812, 633 cm-1; H NMR (400 MHz, DMSO-
IR (KBr): m = 3,449, 2,928, 1,734, 1,682, 1,487, 1,365,
ꢀ
d6): d = 2.38 (s, 3H, CH3), 3.88 (d, J = 15.3 Hz, 1H), 4.29
(d, J = 15.3 Hz, 1H), 6.60 (d, J = 8.9 Hz, 1H), 6.81 (s,
1H), 6.96 (d, J = 8.3 Hz, 1H), 7.02 (d, J = 8.8 Hz, 1H),
7.30 (s, 1H), 7.42 (d, J = 7.9 Hz, 1H), 7.76 (s, 1H), 10.33
(s, 1H, NH, D2O exchangeable), 13.08 (s, 1H, NH, D2O
exchangeable) ppm; 13C NMR (100 MHz, DMSO-d6):
d = 21.4 (CH3), 33.1 (S-CH2), 68.1 (spiro carbon), 111.4,
121.3, 126.9, 127.6, 131.7, 139.6, 143.2, 172.8 (C-2), 174.3
(thiazolidine C=O) ppm; MS: m/z = (ES?) 351.11
[M? ? 1], (ES-) 349.14 [M? - 1].
1,273, 1,234, 1,190, 816, 697, 624 cm-1
;
1H NMR
(400 MHz, DMSO-d6): d = 2.19 (s, 3H, CH3), 3.86 (d,
J = 15.2 Hz, 1H), 4.16 (d, J = 15.2 Hz, 1H), 6.71 (m,
1H), 6.92 (m, 3H), 7.03 (m, 2H), 7.22 (d, J = 7.1 Hz, 1H),
10.61 (s, 1H, NH, D2O exchangeable) ppm; 13C NMR
(100 MHz, DMSO-d6): d = 20.3 (CH3), 33.1 (S-CH2),
69.8 (spiro carbon), 109.7, 111.8, 124.8, 127.2, 128.3,
129.0, 130.5, 131.9, 132.4, 139.2, 173.1 (C-2), 176.1
(thiazolidine C=O) ppm; MS: m/z = (ES?) 329.19
[M? ? 1], (ES-) 327.17 [M? - 1].
5-Methyl-30-phenylspiro[3H-indole-3,20-thiazolidine]-
2,40(1H)-dione (5l, C17H14N2O2S)
5-Fluoro-30-(4-methoxyphenyl)spiro[3H-indole-3,20-
thiazolidine]-2,40(1H)-dione (5t, C17H13FN2O3S)
ꢀ
ꢀ
IR (KBr): m = 3,447, 2,925, 1,734, 1,687, 1,493, 1,363,
IR (KBr): m = 3,447, 2,922, 1,734, 1,688, 1,493, 1,363,
1
1,207, 817, 757, 694 cm-1; H NMR (400 MHz, DMSO-
1,207, 817, 757, 694, 635 cm-1 1H NMR (400 MHz,
;
d6): d = 2.19 (s, 3H, CH3), 3.91 (d, J = 15.5 Hz, 1H), 4.15
(d, J = 15.4 Hz, 1H), 6.65 (d, J = 7.9 Hz, 1H), 6.98 (m,
3H), 7.25 (m, 4H), 10.62 (s, 1H, NH, D2O exchangeable)
ppm; 13C NMR (100 MHz, DMSO-d6): d = 21.1 (CH3),
32.6 (S-CH2), 69.8 (spiro carbon), 109.7, 111.8, 124.8,
127.0, 127.9, 128.3, 129.4, 130.5, 132.2, 139.2, 172.2 (C-
2), 176.5 (thiazolidine C=O); MS: m/z = (ES?) 311.22
[M? ? 1], (ES-) 309.22 [M? - 1].
DMSO-d6): d = 3.70 (s, 3H, OCH3), 3.95 (d, J = 15.3 Hz,
1H), 4.17 (d, J = 15.3 Hz, 1H), 6.74 (m, 2H), 6.82 (d,
J = 8.9 Hz, 2H), 7.02 (d, J = 8.8 Hz, 2H), 7.42 (d,
J = 7.8 Hz, 1H), 10.66 (s, 1H, NH, D2O exchangeable)
ppm; 13C NMR (100 MHz, DMSO-d6): d = 32.5 (S-CH2),
55.4 (OCH3), 70.1 (spiro carbon), 111.8, 113.9, 114.6,
117.6, 118.0, 127.1, 129.9, 138.0, 157.0, 159.2, 171.9 (C-
2), 176.5 (thiazolidine C=O) ppm; MS: m/z = (ES?)
350.11 [M? ? 1], (ES-) 348.10 [M? - 1].
30-(4-Fluorophenyl)-5-methylspiro[3H-indole-3,20-
thiazolidine]-2,40(1H)-dione (5o, C17H13FN2O2S)
30-(4-Methoxyphenyl)-5-methylspiro[3H-indole-3,20-
thiazolidine]-2,40(1H)-dione (5u, C18H16N2O3S)
ꢀ
IR (KBr): m = 3,441, 2,928, 1,731, 1,689, 1,490, 1,354,
1
1,247, 1,198, 1,065, 810, 751, 694, 632 cm-1; H NMR
IR (KBr): m = 3,447, 2,923, 1,734, 1,687, 1,501, 1,373,
ꢀ
(400 MHz, DMSO-d6): d = 2.31 (s, 3H, CH3), 3.96 (d,
J = 15.0 Hz, 1H), 4.11 (d, J = 15.0 Hz, 1H), 6.84 (m,
2H), 6.92 (d, J = 8.8 Hz, 2H), 7.17 (d, J = 8.8 Hz, 2H),
7.29 (d, J = 8.0 Hz, 1H), 10.60 (s, 1H, NH, D2O
exchangeable) ppm; 13C NMR (100 MHz, DMSO-d6):
d = 21.2 (CH3), 32.2 (S-CH2), 70.0 (spiro carbon), 112.1,
114.5, 116.6, 117.9, 118.0, 127.4, 130.2, 138.4, 152.0,
165.2, 171.9 (C-2), 176.5 (thiazolidine C=O) ppm; MS:
m/z = (ES?) 329.23 [M? ? 1], (ES-) 327.18 [M? - 1].
1,205, 811, 735, 678, 635 cm-1
;
1H NMR (400 MHz,
DMSO-d6): d = 2.21 (s, 3H, CH3), 3.79 (s, 3H, OCH3),
3.95 (d, J = 15.0 Hz, 1H), 4.15 (d, J = 15.0 Hz, 1H), 6.79
(m, 2H), 6.82 (d, J = 8.1 Hz, 2H), 7.12 (d, J = 7.8 Hz,
2H), 7.28 (m, 1H), 10.66 (s, 1H, NH, D2O exchangeable)
ppm; 13C NMR (100 MHz, DMSO-d6): d = 21.5, 32.5 (S-
CH2), 55.6 (OCH3), 70.2 (spiro carbon), 112.1, 113.7,
114.6, 117.5, 118.4, 128.0, 129.7, 139.3, 157.0, 164.2,
171.8 (C-2), 176.2 (thiazolidine C=O) ppm; MS:
m/z = (ES?) 341.17 [M? ? 1], (ES-) 339.11 [M? - 1].
30-(4-Methylphenyl)spiro[3H-indole-3,20-thiazolidine]-
2,40(1H)-dione (5p, C17H14N2O2S)
Acknowledgments Authors are grateful to UGC (New Delhi) for
financial assistance.
ꢀ
IR (KBr): m = 3,440, 2,926, 1,739, 1,680, 1,495, 1,363,
1,237, 932, 827, 757, 691, 629 cm-1; 1H NMR (400 MHz,
DMSO-d6): d = 2.23 (s, 3H, CH3), 3.90 (d, J = 15.1 Hz,
1H), 4.15 (d, J = 15.1 Hz, 1H), 6.80 (m, 2H), 6.89 (d,
J = 8.2 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 7.31 (m, 2H),
10.58 (s, 1H, NH, D2O exchangeable) ppm; 13C NMR
(100 MHz, DMSO-d6): d = 21.2 (CH3), 32.3 (S-CH2),
References
1. Wolf M, Masciffi AA (1968) US Pat 3 395 156
2. Wolf M, Masciffi AA (1968) Chem Abstr 69:96504r
123